#Psychedelics #DepressionTreatment #ClinicalResearch
www.medscape.com
Mixed Results for Psilocybin as Blinding Concerns Remain
Two new major studies tackle what many researchers believe to be the central unresolved issue in the assessment of psychedelics as treatment for depression: Whether the apparent benefits are inflated by failures of blinding.
#MentalHealth #ArtificialIntelligence #DepressionTreatment
www.yahoo.com
AI tool helps doctors prescribe antidepressants
Add Yahoo as a preferred source to see more of our stories on Google.
A tool that uses artificial intelligence has been shown to effectively help doctors prescribe antidepressants.
#KetoDiet #MentalHealth #DepressionTreatment
nypost.com
Controversial diet may actually help drug-resistant depression: study
Down in the dumps. Help might be hiding in your fridge.
A new, first-of-its-kind study suggests a controversial diet could ease severe, drug-resistant depression -- with improvements showing up in as little as six weeks.
#DepressionTreatment #FDAApproval #Pharmaceuticals
www.benzinga.com
Why Is GH Research Stock Soaring Monday? - GH Research (NASDAQ:GHRS)
The U. S. Food and Drug Administration (FDA) on Monday lifted the clinical hold on GH Research Plc's (NASDAQ:GHRS) Investigational New Drug Application (IND) for GH001.
#MentalHealth #DepressionTreatment #Neurotechnology
newatlas.com
First US at-home depression kit on its way after trial shows benefits in weeks
In the trial, people wore the headset once a day for about 20-30 minutes per session
In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved the first at-home brain-stimulation device to treat moderate to severe major depressive disorder (MDD).
#MentalHealth #DepressionTreatment #Neurotechnology
newatlas.com
First US at-home depression kit on its way after trial shows benefits in weeks
In the trial, people wore the headset once a day for about 20-30 minutes per session
In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved the first at-home brain-stimulation device to treat moderate to severe major depressive disorder (MDD).
